Clinical Trial Update: Ovarian Dendritic Cell Vaccine Trial [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for an ovarian cancer dendritic cell vaccine; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Loyola University | Conditions: Ovarian Cancer | Phase 2 | Status: UNKNOWN